[Modifiers of calcium action].
Ishikawa
T
T
Department of Pharmacology, Nagoya University School of Medicine, Japan.
Hidaka
H
H
D000818:Animals; D002118:Calcium / Q000378:metabolism* / Q000502:physiology; D002121:Calcium Channel Blockers / Q000494:pharmacology*; D002147:Calmodulin / Q000037:antagonists & inhibitors; D003620:Dantrolene / Q000494:pharmacology; D005707:Gallic Acid / Q000031:analogs & derivatives / Q000494:pharmacology; D006706:Homeostasis; D007474:Ion Exchange; D010640:Phenothiazines / Q000494:pharmacology; D015398:Signal Transduction; D012964:Sodium / Q000378:metabolism
D002121:Calcium Channel Blockers; D002147:Calmodulin; D010640:Phenothiazines; C006014:8-(N,N-diethylamino)octyl-3,4,5-trimethoxybenzoate; D005707:Gallic Acid; D012964:Sodium; D003620:Dantrolene; D002118:Calcium